Trials / Completed
CompletedNCT01176721
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia: a Randomized, Controlled, Double Blind, Two-armed Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- cerbomed GmbH · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, controlled, double-blind, two-armed clinical investigation to show the efficacy and safety of transcutaneous vagus nerve stimulation (t-VNS), applied at the left auricle, in schizophrenia. Study hypothesis: t-VNS may improve negative symptoms, depressive symptoms, cognitive impairment,and aggressive behavior of treated schizophrenia patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | t-VNS verum | Active stimulation of the left auricle by t-VNS |
| DEVICE | t-VNS placebo | Sham stimulation of the left auricle with the t-VNS device |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-07-01
- Completion
- 2012-02-01
- First posted
- 2010-08-06
- Last updated
- 2012-09-12
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01176721. Inclusion in this directory is not an endorsement.